Thyrocare Technologies Limited

Material Risks

AI Risk Summary

Thyrocare faces critical compliance risk with a score of 10.0/10, exposing the company to potential SEBI enforcement action and delisting risk under BRSR Core Expansion mandates—particularly as disclosure obligations tighten for diagnostic sector players. The company's EPR exposure (6.5/10) remains unresolved with uncertain applicability, creating contingent liability of ₹1–4 crore if Extended Producer Responsibility is deemed mandatory for laboratory consumables or diagnostic waste streams. Despite reported zero Scope 1 & 2 emissions, the absence of substantive GHG and water intensity disclosures—both scoring 5.0/10—suggests incomplete environmental accounting that violates BRSR P6 transparency requirements and increases regulatory scrutiny. Immediate priority: formalize EPR applicability assessment and establish verified emissions inventory to mitigate compliance penalties and restore stakeholder confidence.

Source: Thyrocare Technologies Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.